β1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells

scientific article

β1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.18632/ONCOTARGET.1981
P932PMC publication ID4116512
P698PubMed publication ID25003232
P5875ResearchGate publication ID263739686

P2093author name stringWen-Ming Hsu
Ji-Shiang Hung
Jin-Tung Liang
Hong-Shiee Lai
Min-Chuan Huang
John Huang
Mei-Ieng Che
Miao-Juei Huang
Yo-Chuen Lin
P2860cites workGlobal cancer statisticsQ22241238
Molecular cloning and characterization of a novel human beta 1,4-N-acetylgalactosaminyltransferase, beta 4GalNAc-T3, responsible for the synthesis of N,N'-diacetyllactosediamine, galNAc beta 1-4GlcNAcQ24321810
Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancerQ27851456
Identification and expansion of human colon-cancer-initiating cellsQ27860627
A human colon cancer cell capable of initiating tumour growth in immunodeficient miceQ27860831
Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cellsQ28264780
Structural Analysis of the Oligosaccharides Derived from Glycodelin, a Human Glycoprotein with Potent Immunosuppressive and Contraceptive ActivitiesQ28291747
Glycosylation of human pancreatic ribonuclease: differences between normal and tumor statesQ33186313
N-Glycosylation of total cellular glycoproteins from the human ovarian carcinoma SKOV3 cell line and of recombinantly expressed human erythropoietinQ33732475
Angiogenic role for glycodelin in tumorigenesisQ33930637
Understanding resistance to EGFR inhibitors-impact on future treatment strategiesQ34088424
A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor.Q34398347
EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancerQ34421001
The sweet and sour of cancer: glycans as novel therapeutic targetsQ34439560
Propagation of human prostate cancer stem-like cells occurs through EGFR-mediated ERK activation.Q34689170
Epidermal growth factor receptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptorQ35539734
The antifungal drug itraconazole inhibits vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, trafficking, and signaling in endothelial cellsQ35626139
Derivation, propagation and differentiation of human embryonic stem cellsQ35686351
Isolation, propagation, and characterization of rat liver serosal mesothelial cells.Q35834276
Peptide-specific transfer of N-acetylgalactosamine to O-linked glycans by the glycosyltransferases β1,4-N-acetylgalactosaminyl transferase 3 (β4GalNAc-T3) and β4GalNAc-T4Q36217283
Molecular basis for protein-specific transfer of N-acetylgalactosamine to N-linked glycans by the glycosyltransferases β1,4-N-acetylgalactosaminyl transferase 3 (β4GalNAc-T3) and β4GalNAc-T4.Q36217425
Ceramide glycosylation by glucosylceramide synthase selectively maintains the properties of breast cancer stem cellsQ36347787
Knockdown of GnT-Va expression inhibits ligand-induced downregulation of the epidermal growth factor receptor and intracellular signaling by inhibiting receptor endocytosisQ37154050
Cancer stem-like cell properties are regulated by EGFR/AKT/β-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinomaQ37316834
Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR.Q37360712
Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axisQ37420167
Colon cancer stem cells: promise of targeted therapy.Q37737414
Characterisation of insulin-like growth factor receptors and insulin receptors in the human placenta using lectin affinity methodsQ38312878
Apical Golgi localization of N,N'-diacetyllactosediamine synthase, beta4GalNAc-T3, is responsible for LacdiNAc expression on gastric mucosaQ38312893
c-Met function requires N-linked glycosylation modification of pro-MetQ39260851
Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptorQ39459644
A necessary and sufficient determinant for protein-selective glycosylation in vivoQ40042570
Beta1,4-N-acetylgalactosaminyltransferase III enhances malignant phenotypes of colon cancer cellsQ40117775
A novel sialylated N-acetylgalactosamine-containing oligosaccharide is the major complex-type structure present in Bowes melanoma tissue plasminogen activatorQ41693783
Prognostic value of the Glasgow Prognostic Score in metastatic colorectal cancer in the era of anti-EGFR therapies.Q46384821
N-glycan of ErbB family plays a crucial role in dimer formation and tumor promotion.Q46883768
LacdiNAc (GalNAcβ1-4GlcNAc) contributes to self-renewal of mouse embryonic stem cells by regulating leukemia inhibitory factor/STAT3 signaling.Q54388643
Colon cancerQ57758148
Isolation and Culture of Colon Cancer Stem CellsQ60684263
P4510describes a project that usesImageJQ1659584
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectcolon cancerQ18555025
P304page(s)3673-3684
P577publication date2014-06-01
P1433published inOncotargetQ1573155
P1476titleβ1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells
P478volume5

Reverse relations

cites work (P2860)
Q37565255Carbon ion irradiation withstands cancer stem cells' migration/invasion process in Head and Neck Squamous Cell Carcinoma (HNSCC).
Q92402595Clinical significance of the LacdiNAc-glycosylated prostate-specific antigen assay for prostate cancer detection
Q45852537Epigenetic silencing of tumor suppressor candidate 3 confers adverse prognosis in early colorectal cancer
Q58776125Extracellular galectin-3 facilitates colon cancer cell migration and is related to the epidermal growth factor receptor
Q41124448Fentanyl Promotes Breast Cancer Cell Stemness and Epithelial-Mesenchymal Transition by Upregulating α1, 6-Fucosylation via Wnt/β-Catenin Signaling Pathway
Q55639950Glycosylation of Cancer Stem Cells: Function in Stemness, Tumorigenesis, and Metastasis.
Q64166945Identification of a secondary binding site in human macrophage galactose-type lectin by microarray studies: Implications for the molecular recognition of its ligands
Q92537294Identification of mammalian glycoproteins with type-I LacdiNAc structures synthesized by the glycosyltransferase B3GALNT2
Q37405898Integrated glycomic analysis of ovarian cancer side population cells
Q90673235LacdiNAcylation of N-glycans in MDA-MB-231 human breast cancer cells results in changes in morphological appearance and adhesive properties of the cells
Q27728015Molecular basis for recognition of the cancer glycobiomarker LacdiNAc (GalNAc(β1-4)GlcNAc) by Wisteria floribunda agglutinin
Q41171796New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma
Q59327036Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells
Q36182285Protein O-Mannosylation in the Murine Brain: Occurrence of Mono-O-Mannosyl Glycans and Identification of New Substrates
Q28069952Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma
Q38510649The "next-generation" knowledge of papillary thyroid carcinoma
Q39757304The directed migration of gonadal distal tip cells in Caenorhabditis elegans requires NGAT-1, a ß1,4-N-acetylgalactosaminyltransferase enzyme.
Q37713999The lactoferricin B-derived peptide, LfB17-34, induces melanogenesis in B16F10 cells
Q26779166The role of N-glycans in colorectal cancer progression: potential biomarkers and therapeutic applications
Q35247136Trefoil factor family domains represent highly efficient conformational determinants for N-linked N,N'-di-N-acetyllactosediamine (LacdiNAc) synthesis

Search more.